Revelation Biosciences, Inc.
REVB- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001810560
No open-market purchases or sales by Revelation Biosciences, Inc. insiders were filed in the last 90 days; 12 institutions reported holding it in 13F filings for Q2 2026, worth $313.2K in total; no superinvestor holds it.
Other share classesREVBW
Q1 2022 vs. Q4 2021
How the institutions holding Revelation Biosciences, Inc. changed between Q4 2021 and Q1 2022.
All holders in Q1 2022All holders in Q4 2021
| Measure | Q4 2021 | Q1 2022 | Change |
|---|---|---|---|
| Holders | 2 | 16 | +14 |
| Shares | 64.3K | 3.02M | +2.95M (+4,593.4%) |
| Value | $657.0K | $3.44M | +$2.78M (+423.2%) |
New holders (16)
Institutions that held Revelation Biosciences, Inc. at the end of Q1 2022 but not at the end of Q4 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| AXA S.A. | 1,958,984 | $2.23M | 0.01% |
| Monashee Investment Management LLC | 817,562 | $932.0K | 0.27% |
| Citadel Advisors LLC | 42,633 | $49.0K | 0.00% |
| Bridgeway Capital Management, LLC | 39,800 | $45.0K | 0.00% |
| Two Sigma Investments, LP | 32,540 | $37.0K | 0.00% |
| HRT Financial LP | 23,751 | $27.0K | 0.00% |
| Ergoteles LLC | 22,327 | $25.0K | 0.00% |
| Mayflower Financial Advisors, LLC | 21,425 | $24.0K | 0.00% |
| Jane Street Group, LLC | 19,536 | $22.0K | 0.00% |
| Virtu Financial LLC | 14,906 | $17.0K | 0.00% |
| Valeo Financial Advisors, LLC | 10,000 | $11.0K | 0.00% |
| Morgan Stanley | 4,289 | $5.00K | 0.00% |
| Tower Research Capital LLC (TRC) | 3,502 | $4.00K | 0.00% |
| UBS Group AG | 3,736 | $4.00K | 0.00% |
| Citigroup Inc | 1,830 | $2.00K | 0.00% |
| Wells Fargo & Company | 32 | $0 | 0.00% |
Sold out (2)
Institutions that held Revelation Biosciences, Inc. at the end of Q4 2021 and filed for Q1 2022 without it.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| Marshall Wace, LLP | 49,678 | $508.0K |
| Yakira Capital Management, Inc. | 14,600 | $149.0K |